HOXB9 was found to be overexpressed in lung adenocarcinoma and human breast cancer, whereas in colon adenocarcinoma, pancreatic ductal adenocarcinoma and gastric carcinoma patients, its expression is decreased15–19,21. Here, HOXB9 is linked to pancreatic ductal adenocarcinoma.